For the past few years, I have been working in the pharmaceutical industry, in the area of quality. On a daily basis, I deal with medicines — their safety, their compliance, and whether they truly meet the standards and regulations they are supposed to meet.
The longer I work in this field, the more one thing continues to impress me: how incredibly complex the medicine supply chain really is. For most people, it appears simple. A medicine is produced, delivered to a pharmacy, and given to a patient. End of story.
In reality, it is far more complicated.
Behind every tablet, vial, or inhaler, there is a global network of raw material suppliers, manufacturers, laboratories, logistics providers, quality systems, and regulatory requirements. One single medicine can pass through several countries before it reaches the patient. A problem at any point — a quality deviation, a manufacturing delay, or a regulatory change — can have real and immediate consequences.
This blog was created to bridge the gap between these two worlds.
It is a place for patients and non-experts who want to understand where medicines come from and why shortages or safety issues happen. But it is also a space for professionals, where I will share insights on changing pharmaceutical regulations, with a particular focus on the Netherlands and the European context, and how these changes affect quality systems, supply chains, and daily practice.
I will write about medicines, quality, compliance, supply chains, shortages, and falsified products — explaining complex topics in a clear and practical way, without unnecessary jargon, but without oversimplifying what truly matters.
The goal is not to alarm, but to inform. Because better understanding leads to better decisions — for patients, pharmacists, and professionals across the healthcare system.
Thank you for being here.